Gilteritinib

Xospata

Treatment Description

Gilteritinib is a tyrosine kinase inhibitor that is approved for acute myeloma leukemia patients who are FLT-3 positive. It is currently being studied for use in several different indications.

Participating Centers

There are 140 centers running trials with this treatment. Enter a location below to find the closest center.